Rating History for Eiger BioPharma (EIGR) by Citi
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 12/3/2021 | Yigal Nochomovitz | Maintain | Buy (N/A) |
23.00 (27.00) |
|
Details | |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 12/3/2021 | Yigal Nochomovitz | Maintain | Buy (N/A) |
23.00 (27.00) |
|
Details | |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||